Advanced Cardiology and Hemostaseology Research

The main research of this center is centered around two main directions. The first is from the field of cardiology, with focus on the heart failure continuum and cardiovascular risk associated with dislipdemia and the second is from the field of  blood hemostaseology and blood clotting, including the most severe vascular  event such as the case of pulmonary embolism.

The heart failure is an increasing burden that is marred by superimposed cardiovascular events such as acute coronary syndromes, angina pectoris or coronary artery disease. In these cases the dyslipidemia is the predisposing  and underlying factor. The study of this population with increased dislipidemic parameters is of particular interest in the light of new classification of heart failure proposed by the European Society of Cardiology.

With increasing incidence of newly diagnosed neoplasia, increased survival of bed ridden patients, increasing age, the incidence of embolic events is increasing worldwide. Pulmonary embolism is one of the main causes of mortality and sudden cardiovascular death, with dreadful complications on the long term. The screening of patients at risk, improved algorithms for early detection and appropriate treatment is desirable. These aspects have improved the survival of these patients and extended anticoagulation have provided better outcomes.

We believe that these diseases are of particular interest from clinical, social, economic and psychological point of view and our center can contribute to a better understanding of these implications, in a region of Europe that lacks controlled studies.